Isolation and characterization of human recombinant antibodies endowed with the antigen-specific, major histocompatibility complex-restricted specificity of T cells directed toward the widely expressed tumor T-cell epitopes of the telomerase catalytic subunit

Cancer Research

Volumn 62, Issue 11, 2002, Pages 3184-3194

  Lev, Avital ^a   Denkberg, Galit ^a   Cohen, Cyril J ^a   Reiter, Yoram ^a   Tzukerman, Maty ^a   Skorecki, Karl L ^a   Chames, Patrick ^b   Hoogenboom, Hennie R ^b,c  

^a TECHNION ISRAEL INSTITUTE OF TECHNOLOGY   (Israel)

^b MAASTRICHT UNIVERSITY   (Netherlands)

^c CHU SART TILMAN   (Belgium)

Author keywords

[No Author keywords available]

Indexed keywords

EPITOPE; HLA A2 ANTIGEN; IMMUNOGLOBULIN F(AB) FRAGMENT; RECOMBINANT ANTIBODY; T LYMPHOCYTE RECEPTOR; TELOMERASE;

ANTIBODY ISOLATION; ANTIBODY SPECIFICITY; ANTIGEN PRESENTATION; ARTICLE; CONTROLLED STUDY; CYTOTOXIC T LYMPHOCYTE; EFFECTOR CELL; ENZYME ACTIVE SITE; ENZYME LINKED IMMUNOSORBENT ASSAY; FLOW CYTOMETRY; HUMAN; HUMAN CELL; IMMUNOTHERAPY; MAJOR HISTOCOMPATIBILITY COMPLEX; POLYACRYLAMIDE GEL ELECTROPHORESIS; PRIORITY JOURNAL; T LYMPHOCYTE; TUMOR;

ANIMALS; ANTIBODY SPECIFICITY; ANTIGEN-PRESENTING CELLS; DNA-BINDING PROTEINS; EPITOPES, T-LYMPHOCYTE; FLOW CYTOMETRY; HLA-A2 ANTIGEN; HUMANS; IMMUNOGLOBULIN FRAGMENTS; MICE; RECEPTORS, ANTIGEN, T-CELL; RECOMBINANT PROTEINS; T-LYMPHOCYTES; TELOMERASE; TRANSFECTION;

EID: 0036605976     PISSN: 00085472     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (46)

1. Human tumor antigens recognized by T lymphocytes
2. Progress in human tumour immunology and immunotherapy
3. A listing of human tumor antigens recognized by T cells
4. Phenotypic analysis of antigen-specific T lymphocytes
5. Characterization of circulating T cells specific for tumor-associated antigens in melanoma patients
6. Design and evaluation of antigen-specific vaccination strategies against cancer
7. The use of dendritic cells for cancer vaccination
8. Regression of human metastatic renal cell carcinoma after vaccination with tumor cell-dendritic cell hybrids
9. Correctly folded T-cell receptor fragments in the periplasm of Escherichia coli. Influence of folding catalysts
10. A recombinant antibody with the antigen-specific, major histocompatibility complex-restricted specificity of T cells
11. Localization, quantitation, and in situ detection of specific peptide-MHC class I complexes using a monoclonal antibody
12. Direct delivery of exogenous MHC class I molecule-binding oligopeptides to the endoplasmic reticulum of viable cells
13. Production, specificity, and functionality of monoclonal antibodies to specific peptide-major histocompatibility complex class II complexes formed by processing of exogenous protein
14. Antigen-unspecific B cells and lymphoid dendritic cells both show extensive surface expression of processed antigen-major histocompatibility complex class II complexes after soluble protein exposure in vivo or in vitro
15. Characterization and quantitation of peptide-MHC complexes produced from hen egg lysozyme using a monoclonal antibody
16. A novel MHC class lI epitope expressed in thymic medulla but not cortex
17. Immunomodulation of experimental allergic encephalomyelitis by antibodies to the antigen-complex
18. Visualization of myelin basic protein (MBP) T-cell epitopes in multiple sclerosis lesions using a monoclonal antibody specific for the human histocompatibility leukocyte antigen (HLA)-DR2-MBP 85-99 complex
19. Peptide-specific killing of antigen-presenting cells by a recombinant antibody-toxin fusion protein targeted to major histocompatibility complex/peptide class I complexes with T-cell receptor-like specificity
20. Direct selection of a human antibody fragment directed against the tumor T-cell epitope HLA-A-MAGE-A from a nonimmunized phage-Fab library
21. Telomeres and their control
22. Reversing time: Origin of telomerase
23. Telomerase and cancer
24. Specific association of human telomerase activity with immortal cells and cancer
25. Developmental and tissue-specific regulation of mouse telomerase and telomere length
26. hEST2, the putative human telomerase catalytic subunit gene, is up-regulated in tumor cells and during immortalization
27. Telomerase catalytic subunit homologs from fission yeast and human
28. Telomere shortening associated with chromosome instability is arrested in immortal cells which express telomerase activity
29. Telomerase activity in human ovarian carcinoma
30. Telomerase, cell immortality, and cancer
31. The telomerase catalytic subunit is a widely expressed tumor-associated antigen recognized by cytotoxic T lymphocytes
32. Cytotoxic T cell immunity against telomerase reverse transcriptase in humans
33. Telomerase activity in normal leukocytes and in hematologic malignancies
34. Identification of human telomerase reverse transcriptase-derived peptides that induce HLA-A24-restricted antileukemia cytotoxic T lymphocytes
35. A large nonimmunized human Fab fragment phage library that permits rapid isolation and kinetic analysis of high affinity antibodies
36. Recombinant human single-chain MHC-peptide complexes made from E. coli by in vitro refolding: Functional single-chain MHC-peptide complexes and tetramers with tumor associated antigens
37. HLA-A2.1-restricted education and cytolytic activity of CD8(+) T lymphocytes from β2 microglobulin (β2m) HLA-A2.1 monochain transgenic H-2Db β2m double knockout mice
38. Critical role for CD8 in binding of MHC tetramers to TCR: CD8 antibodies block specific binding of human tumor-specific MHC-peptide tetramers to TCR
39. Analysis of endogenous peptides bound by soluble MHC class I molecules: A novel approach for identifying tumor-specific antigens
40. Human telomerase reverse transcriptase promoter regulation in normal and malignant human ovarian epithelial cells
41. Targeted therapy of cancer with recombinant immunotoxins
42. Targeted cytokines for cancer immunotherapy
43. Bi-specific antibody therapy for the treatment of cancer
44. Shared fine specificity between T-cell receptors and an antibody recognizing a peptide/major histocompatibility class I complex
45. A phage display selected Fab fragment with MHC class I-restricted specificity for MAGE-A allows for retargeting of primary human T lymphocytes
46. Improving antibody affinity by mimicking somatic hypermutation in vitro